Literature DB >> 8051135

Constitutive ATP hydrolysis and transcription activation by a stable, truncated form of Rhizobium meliloti DCTD, a sigma 54-dependent transcriptional activator.

J H Lee1, D Scholl, B T Nixon, T R Hoover.   

Abstract

The dctD gene product (DCTD) activates transcription from dctA by the sigma 54-holoenzyme form of RNA polymerase in Rhizobium meliloti. We have purified a constitutively active form of R. meliloti DCTD that lacks 142 amino acid residues from the N terminus (designated DCTDL143). Purified DCTDL143 recognized the DCTD-binding sites at the dctA promoter region and catalyzed the isomerization of closed complexes between sigma 54-holoenzyme and the dctA promoter to open complexes. Like the related sigma 54-dependent activators NTRC and NIFA, a purine nucleoside triphosphate with a hydrolyzable beta-gamma bond was required prior to transcription initiation for this isomerization. DCTDL143 hydrolyzed purine nucleoside triphosphates but not pyrimidine nucleoside triphosphates. As observed with NTRC-phosphate, the specific activity for the ATPase of DCTDL143 was strongly dependent on the enzyme concentration and was stimulated by DNA fragments bearing the binding sites for the protein. These DNA fragments increased the Vmax for MgATP hydrolysis but did not significantly lower the apparent Km for MgATP. These data are consistent with the idea proposed for related activators that DCTDL143 must assemble into an active, oligomeric form before it can hydrolyze MgATP and presumably activate transcription.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8051135

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  The amino terminus of Salmonella enterica serovar Typhimurium sigma(54) is required for interactions with an enhancer-binding protein and binding to fork junction DNA.

Authors:  M T Kelly; T R Hoover
Journal:  J Bacteriol       Date:  2000-01       Impact factor: 3.490

2.  An active role for a structured B-linker in effector control of the sigma54-dependent regulator DmpR.

Authors:  E O'Neill; P Wikström; V Shingler
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

3.  Transcription initiation-defective forms of sigma(54) that differ in ability To function with a heteroduplex DNA template.

Authors:  M T Kelly; J A Ferguson; T R Hoover
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

4.  Identification and physical characterization of the HbpR binding sites of the hbpC and hbpD promoters.

Authors:  David Tropel; Jan Roelof van der Meer
Journal:  J Bacteriol       Date:  2002-06       Impact factor: 3.490

5.  Purification and characterization of the AAA+ domain of Sinorhizobium meliloti DctD, a sigma54-dependent transcriptional activator.

Authors:  Hao Xu; Baohua Gu; B Tracy Nixon; Timothy R Hoover
Journal:  J Bacteriol       Date:  2004-06       Impact factor: 3.490

6.  Nucleoprotein complex formation by the enhancer binding protein nifA.

Authors:  X Y Wang; A Kolb; W Cannon; M Buck
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

7.  Targeted mutagenesis of sigma54 activator proteins in Myxococcus xanthus.

Authors:  L Gorski; D Kaiser
Journal:  J Bacteriol       Date:  1998-11       Impact factor: 3.490

8.  Alterations within the activation domain of the sigma 54-dependent activator DctD that prevent transcriptional activation.

Authors:  Y K Wang; T R Hoover
Journal:  J Bacteriol       Date:  1997-09       Impact factor: 3.490

9.  ADPase activity of recombinantly expressed thermotolerant ATPases may be caused by copurification of adenylate kinase of Escherichia coli.

Authors:  Baoyu Chen; Tatyana A Sysoeva; Saikat Chowdhury; Liang Guo; B Tracy Nixon
Journal:  FEBS J       Date:  2009-02       Impact factor: 5.542

10.  Effector-mediated stimulation of ATPase activity by the sigma 54-dependent transcriptional activator FHLA from Escherichia coli.

Authors:  S Hopper; A Böck
Journal:  J Bacteriol       Date:  1995-05       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.